Yusuke Nakatsu

Xanthine Oxidoreductase Is Involved in Macrophage Foam Cell Formation and Atherosclerosis Development

Akifumi Kushiyama, Hirofumi Okubo, Hideyuki Sakoda et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 122 citations · Full text

Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus

Shirong Qiang, Yusuke Nakatsu, Yasuyuki Seno et al. · Diabetology & Metabolic Syndrome · 2015 · 112 citations · Full text

<i>Lactobacillus casei</i>strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model

Hirofumi Okubo, Hideyuki Sakoda, Akifumi Kushiyama et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2013 · 101 citations

Nutrition, Dysbiosis, Rodent Model +17

The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice

Yusuke Nakatsu, Hiroki Kokubo, Bumdelger Batmunkh et al. · International Journal of Molecular Sciences · 2017 · 88 citations · Full text

Immunology, Native Apoe Ko, Hyperlipidemia +22

Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity

Toshiaki Fukushima, Hidehito Yoshihara, Haruka Furuta et al. · Nature Communications · 2015 · 87 citations · Full text